Genfit   Report issue

For profit Phase 1 Phase 3
Founded: Loos France (1999)

Organization Overview

First Clinical Trial
2009
NCT01271751
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Chief Medical Officer, Genfit | Development Director Genfit, France | Genfit | Genfit, France | GENFIT, France